
### [MONDO:0007963](http://purl.obolibrary.org/obo/MONDO_0007963)
**Label:** CMM1

**Subclasses:** [MONDO:0013133](http://purl.obolibrary.org/obo/MONDO_0013133) (melanoma, cutaneous malignant, susceptibility to, 5), [MONDO:0007965](http://purl.obolibrary.org/obo/MONDO_0007965) (melanoma, malignant familial intraocular), [MONDO:0007964](http://purl.obolibrary.org/obo/MONDO_0007964) (dysplastic nevus syndrome), [MONDO:0013510](http://purl.obolibrary.org/obo/MONDO_0013510) (melanoma, cutaneous malignant, susceptibility to, 6), [MONDO:0012183](http://purl.obolibrary.org/obo/MONDO_0012183) (melanoma, cutaneous malignant, susceptibility to, 3), [MONDO:0014368](http://purl.obolibrary.org/obo/MONDO_0014368) (melanoma, cutaneous malignant, susceptibility to, 10), [MONDO:0018961](http://purl.obolibrary.org/obo/MONDO_0018961) (familial melanoma), [MONDO:0014056](http://purl.obolibrary.org/obo/MONDO_0014056) (melanoma, cutaneous malignant, susceptibility to, 9), [MONDO:0011954](http://purl.obolibrary.org/obo/MONDO_0011954) (CMM4), 

**Corr. equiv. classes:** [OMIM:613099](http://purl.obolibrary.org/obo/OMIM_613099), [OMIM:615134](http://purl.obolibrary.org/obo/OMIM_615134), [Orphanet:618](http://www.orpha.net/ORDO/Orphanet_618), [OMIM:613972](http://purl.obolibrary.org/obo/OMIM_613972), [OMIM:615848](http://purl.obolibrary.org/obo/OMIM_615848), [OMIM:608035](http://purl.obolibrary.org/obo/OMIM_608035), [OMIM:609048](http://purl.obolibrary.org/obo/OMIM_609048), [OMIM:155601](http://purl.obolibrary.org/obo/OMIM_155601), [OMIM:155700](http://purl.obolibrary.org/obo/OMIM_155700), 

**Class expressions from DL-Learner:**

- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) 45.53%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 45.53%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) 39.81%
- [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 38.89%
- [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) 38.66%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0002861](http://purl.obolibrary.org/obo/HP_0002861) (Melanoma) 31.98%
- Thing 28.91%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 28.91%
- [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) 28.22%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 25.61%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 25.45%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) 24.21%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 23.55%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 23.24%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) 18.35%


